PolyPid (NASDAQ:PYPD) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of…
PolyPid (NASDAQ:PYPD) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.41, missing the consensus estimate of $-0.33 by $0.08 per share. Revenue came in at , meeting the estimate of .
PolyPid's stock moved following the earnings release. The stock currently trades at $4.60 with a market capitalization of $40.5M.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · PYPD
$5.16
Down: -$0.01 · -0.19%
Live quote updated
Keep reading
